Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC6 pseudogene 10 (TRPC6P10) is classified as a pseudogene based on current genomic annotation. It does not encode a functional protein product and is not known to have any intrinsic molecular function, involvement in signal transduction, disease association, or utility as a drug target, biomarker, or therapeutic agent. This is distinct from the functional protein “Transient receptor potential cation channel subfamily C member 6 (TRPC6),” an ion channel implicated in calcium signaling and certain kidney diseases[1][3][7]. TRPC6P10 appears only to be a genomic relic without clinical or pharmacological significance[2][6]. If your intention was to reference the active ion channel, please see information on TRPC6 instead. For TRPC6P10, there is no evidence of physiological or therapeutic utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TRPC6 pseudogene 10 (TRPC6P10).